MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

Home・Akcijų sąrašas・Evolent Health Inc

Evolent Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

3.93 4.52

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.68

Max

3.98

Pagrindiniai rodikliai
By Trading Economics
Pajamos	30M -21M
Pardavimai	35M 480M
Pelno marža	-4.351
Darbuotojai	4,500
EBITDA	512K 15M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+147.48% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-19

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-342M 437M
Ankstesnė atidarymo kaina	-0.59
Ankstesnė uždarymo kaina	3.93

Naujienos nuotaikos

By Acuity

40%

60%

106 / 361 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

10.33 / 10.95 Palaikymas ir pasipriešinimas

Evolent Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-20 23:43; UTC

Rinkos pokalbiai

Gold Consolidates; May Face Technical Correction -- Market Talk

2026-01-20 23:42; UTC

Rinkos pokalbiai

Nikkei May Fall Amid Concerns Over U.S.-Europe Trade Relations -- Market Talk

2026-01-20 23:41; UTC

Uždarbis

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- 2nd Update

2026-01-20 23:29; UTC

Rinkos pokalbiai

RBA Rate Hike in February Would Be a Painful One -- Market Talk

2026-01-20 23:26; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-20 23:26; UTC

Rinkos pokalbiai

James Hardie Appeals More as Reece's U.S. Strategy Comes Under Scrutiny -- Market Talk

2026-01-20 22:45; UTC

Įsigijimai, susijungimai, perėmimai

ACCC: Ampol-EG Deal Is First Assessment Subject to Phase 2 Review Under New Merger Control Regime

2026-01-20 22:45; UTC

Įsigijimai, susijungimai, perėmimai

ACCC Seeks Submissions in Response to Phase 2 Notice by February 4

2026-01-20 22:44; UTC

Įsigijimai, susijungimai, perėmimai

ACCC: Ampol's Offer to Sell 19 Retail Fuel Sites Doesn't Adequately Address Issues

2026-01-20 22:44; UTC

Įsigijimai, susijungimai, perėmimai

ACCC Identifies 115 EG Sites Where Deal Could Substantially Lessen Competition

2026-01-20 22:43; UTC

Įsigijimai, susijungimai, perėmimai

ACCC Says Deal Could Substantially Lessen Competition in Retail Supply of Petrol, Diesel in Several Markets in Australia

2026-01-20 22:43; UTC

Įsigijimai, susijungimai, perėmimai

Ampol's Acquisition of EG Australia to Undergo In-Depth Review by Competition Regulator

2026-01-20 22:27; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Plans to Roll Out New Mobile User Interface Later This Year, Co-CEO Says

2026-01-20 22:25; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Co-CEO Sees Uptick in Engagement for TV-Based Games

2026-01-20 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Would Keep 45-Day Theater Release Window for Warner Bros. Films, Co-CEO Says

2026-01-20 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Excited to Strengthen Warner Bros.'s Theatrical-Distribution Business, Co-CEO Says

2026-01-20 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Pleased With Early Results for Podcasts, Co-CEO Says

2026-01-20 22:18; UTC

Uždarbis

Netflix Stock Is Falling. This Is Overshadowing the Streamer's Earnings Beat. -- Barrons.com

2026-01-20 22:17; UTC

Įsigijimai, susijungimai, perėmimai

Netflix's Live Events Are Boosting Retention, Co-CEO Says

2026-01-20 22:16; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Remains 'Very Excited' About Live-Events Offering, Co-CEO Says

2026-01-20 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Netflix's Proposed Deal for Warner Bros. Would Protect, Create Jobs, Co-CEO Says

2026-01-20 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Competes for Attention Across Streaming, Broadcast, Cable, Gaming, Social Media, Video Platforms, Co-CEO Says

2026-01-20 22:13; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Co-CEO: TV Landscape Has Never Been More Competitive

2026-01-20 22:11; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Confident Warner Bros. Deal Would Pass Regulatory Review, Co-CEO Says

2026-01-20 22:10; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Would Leverage Global Footprint, Streaming Expertise to Improve Warner Bros.'s HBO Max Service, Co-CEO Says

2026-01-20 22:08; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Won't Raise Prices During Regulatory-Review Process for Pending Warner Bros. Deal, Co-CEO Says

2026-01-20 22:07; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Sees Warner Bros. as Another Mechanism to Improve Offerings, Co-CEO Says

2026-01-20 22:06; UTC

Uždarbis

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- Update

2026-01-20 22:00; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

ESG Roundup: Market Talk

2026-01-20 21:50; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Evolent Health Inc Prognozė

Kainos tikslas

By TipRanks

147.48% į viršų

12 mėnesių prognozė

Vidutinis 9.33 USD 147.48%

Aukščiausias 16 USD

Žemiausias 5 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Evolent Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

14 ratings

Pirkti

Laikyti

Parduoti

Remiantis 14 analitikų, pateikusių Evolent Health Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

10.33 / 10.95Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Rinkos nuotaikos

By Acuity

106 / 361 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.